We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI Tool Uses ECG to Predict Mortality Risk after Surgeries and Procedures

By HospiMedica International staff writers
Posted on 18 Dec 2023

An artificial intelligence (AI) algorithm uses electrocardiograms (ECGs) to accurately predict how patients would fare after surgeries and procedures. More...

Researchers at the Smidt Heart Institute at Cedars-Sinai (Los Angeles, CA, USA) have trained the AI model to analyze pre-operative ECGs, uncovering a novel application for this test, which dates back to the late 19th century. An ECG, a standard test that records the heart's electrical activity by placing electrodes on the skin, helps assess heart function. The study included patients undergoing various surgical procedures, encompassing open heart surgery, major surgeries, and less invasive techniques using catheters or endoscopes.

The research team correlated pre-surgical or pre-procedural ECGs of the patients with their subsequent post-operative outcomes. They tasked the AI algorithm with detecting correlations or patterns within the ECG waveforms. While the algorithm classified most patients as low risk, it flagged others as high risk, revealing that these individuals had an almost nine times higher likelihood of post-operative mortality. Currently, physicians gauge a patient's surgery risk based on medical society guidelines. The investigators at Cedars-Sinai are exploring how to adapt this AI algorithm into a web-based application, aiming to make it broadly accessible to both medical professionals and patients.

“This is the first electrocardiogram-based AI algorithm that predicts post-operative mortality,” said David Ouyang, MD, a cardiologist in the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai. “Previously, algorithms have been used to assess long-term mortality as well as individual disease states, but determining post-surgical outcomes helps inform the actual decision to do surgery.”

“As it now stands, clinicians only have a modest ability to predict how a patient is going to do after surgery,” added Ouyang. “Current clinical risk prediction tools are insufficient. This AI model could potentially be used to determine exactly which patients should undergo an intervention and which patients might be too sick.”

Related Links:
Cedars-Sinai 


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.